Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-15

FDA Approved: SUCRALFATE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for sucralfate, enabling a generic version to come to market. Sucralfate is a mucosal protectant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRALFATE (SUCRALFATE)

Snippet

ORIG AP for SUCRALFATE (SUCRALFATE)